10-K: Marpai Faces Going Concern Doubt Amid Revenue Decline, Restructuring

Marpai Inc. reported a significant revenue decline and ongoing operating losses for 2025, leading to substantial doubt about its ability to continue as a going concern, despite strategic restructuring efforts.

Summary

• Reported a net loss of $16.6 million for the year ended December 31, 2025, an improvement from $22.1 million in 2024.
• Revenue decreased by 36% to $18.1 million in 2025 from $28.2 million in 2024, primarily due to customer turnover.
• Experienced a customer attrition rate of 28% in 2025.
• Operating loss improved by 39% to $13.6 million in 2025 from $22.1 million in 2024.
• As of December 31, 2025, the company had an accumulated deficit of $115.4 million and negative working capital of $15.4 million.
• Unrestricted cash on hand was $133 thousand as of December 31, 2025.
• The independent auditor's report includes an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.
• Initiated a strategic operational realignment in early 2026 to consolidate claims processing onto a single cloud-based engine, expecting $465 thousand in restructuring charges in H1 2026 and significant annualized operating expense savings in H2 2026.
• Settled a lawsuit with Messer Financial Group Inc. for breach of contract, agreeing to pay $10 thousand cash and 400,000 restricted stock units in installments, with a potential additional $250 thousand cash or stock payment.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing with significant concern due to the explicit 'going concern' warning, substantial revenue decline, high customer attrition, and ongoing need for external financing, despite some improvements in net loss and operating cash flow.

Positives

• Net loss decreased by 25% to $16.6 million in 2025 from $22.1 million in 2024.
• Operating loss improved by 39% to $13.6 million in 2025 from $22.1 million in 2024.
• Net cash used in operating activities decreased by $7.7 million, from $15.2 million in 2024 to $7.5 million in 2025.
• General and administrative expenses decreased by 13% ($1.7 million) due to streamlining TPA operations.
• Sales and marketing expenses decreased by 38% ($675 thousand) due to streamlining efforts.
• Facilities expenses decreased by 56% ($725 thousand) due to decommissioning unutilized facilities.
• Depreciation and amortization expenses decreased by 83% ($1.9 million) due to full amortization of certain fixed assets and intangible asset impairments in 2024.
• Achieved a $3.0 million gain on forgiveness of other liability in 2024 due to meeting reduction criteria with AXA.
• Strategic operational realignment is expected to achieve greater scalability, improved data accuracy, and a more streamlined cost structure, leading to significant annualized operating expense savings starting in the second half of 2026.

Negatives

• Revenue decreased by 36% to $18.1 million in 2025 from $28.2 million in 2024, primarily due to customer turnover.
• Experienced a high customer attrition rate of 28% in 2025.
• The company has an accumulated deficit of $115.4 million and negative working capital of $15.4 million as of December 31, 2025.
• Unrestricted cash on hand was only $133 thousand as of December 31, 2025.
• The independent auditor's report contains an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.
• Interest expense increased by 19% to $3.2 million in 2025 from $2.7 million in 2024 due to additional financing.
• Incurred $465 thousand in estimated pre-tax restructuring charges in the first half of 2026, including severance and software contract termination fees.
• The company's common stock was delisted from Nasdaq and commenced trading on the OTCQX Market effective May 29, 2024.
• The company's common stock is currently deemed "penny stock," making it more difficult for investors to sell shares and potentially reducing liquidity.
• Research and development expenses decreased by 76% ($22 thousand) due to a shift in resources to existing operations, potentially indicating reduced investment in future innovation.

Risks

• Substantial doubt about the ability to continue as a going concern due to recurring operating losses, negative cash flows, accumulated deficit, and insufficient capital.
• Inability to obtain additional capital may force scaling back operations or divestment of assets.
• High annual customer attrition rate (28% in 2025) and potential loss, termination, or renegotiation of client contracts could materially adversely affect financial conditions and operating results.
• Exposure to liabilities from ongoing disputes and lawsuits, including ERISA fiduciary liability claims.
• Failure of member guidance programs to provide accurate and timely predictions could lead to low customer satisfaction.
• Issues in the use of Data Analytics and AI, including deep learning, could result in reputational harm or liability.
• Reliance on healthcare benefits brokers as the principal sales channel, with no allegiance to the company, could lead to client attrition if satisfaction is not met.
• Changes in pricing models, such as a shift to shared savings, could introduce revenue risk if cost savings are not achieved as expected.
• Long and unpredictable sales cycles require considerable investment without assurance of success.
• Security breaches or unauthorized access to client data (including PHI) could lead to litigation, reputational damage, and significant liabilities.
• Reliance on internet infrastructure, bandwidth providers, data center providers, and other third parties, with any failure or interruption potentially exposing the company to litigation and negatively impacting relationships.
• Inability to maintain licenses for third-party software or errors in licensed software could limit functionality and increase costs.
• Failure to protect intellectual property rights could impair the ability to protect proprietary technology and brand, and lead to costly litigation.
• Inadequate defense against intellectual property piracy in foreign jurisdictions.
• Potential lawsuits from third parties for alleged infringement of proprietary rights or misappropriation of intellectual property.
• Failure to comply with open-source software licenses could adversely affect the business, potentially requiring public release of proprietary code.
• Extensive and complex government regulation of the healthcare industry (False Claims, HIPAA, Anti-Kickback, Corporate Practice of Medicine, Medical Device Laws) creates compliance risks and potential for significant penalties.
• Uncertain and evolving healthcare regulatory and political framework, including potential expiration of enhanced premium tax credits and changes to self-insured plan regulation.
• Changes in laws and regulations related to the Internet or access to the Internet generally could adversely impact the business.
• Increases in stop-loss insurance premiums or reduced availability could adversely affect clients' willingness to remain self-insured, reducing demand for services.
• Requirements of being a public company strain resources, divert management's attention, and increase legal, accounting, and financial compliance costs.
• Issuance of additional capital stock in the future will dilute existing stockholders.
• No intention to pay dividends, so return on investment depends solely on stock price appreciation.
• Market price of common stock may be volatile and decline regardless of operating performance.
• Bylaws designate Delaware courts as the exclusive forum for certain litigation, potentially limiting stockholders' ability to obtain a favorable judicial forum.
• Common stock is deemed "penny stock," making it more difficult for investors to buy and sell shares and reducing liquidity.

Future Outlook

The company projects a need for additional capital to fund current operations and capital investment requirements until it scales to a revenue level that permits cash self-sufficiency. Management expects to implement additional cost reduction actions. A strategic operational realignment initiated in early 2026, consolidating claims processing onto a single cloud-based engine and reducing workforce by 11 positions, is expected to be substantially complete by the end of the second quarter of 2026, leading to significant annualized operating expense savings starting in the second half of 2026.

Management Comments

• "We currently project that we will need additional capital to fund our current operations and capital investment requirements until we scale to a revenue level that permits cash self-sufficiency."
• "Management has determined that our liquidity condition raises substantial doubt about our ability to continue as a going concern through twelve months from the date of these consolidated financial statements."
• "We have initiated remedial actions to reduce future attrition rates, [but] there is no assurance that we will be able to reduce the attrition rates."
• "We expect to fund the $465 thousand in restructuring-related cash payments through existing cash on hand. We do not believe these payments will materially impact our ability to meet our other short-term or long-term liquidity requirements. However, the anticipated reduction in go-forward operating expenses is expected to improve our cash flow from operations in future periods."

Industry Context

StockSavvy.ai notes that Marpai operates in a highly competitive and fragmented TPA sector, which is experiencing continued growth in self-funded and alternative funding insurance plans among small and mid-sized enterprises (SMEs). The industry is driven by employers' ongoing challenges to balance benefit costs with competitive offerings amid rising healthcare expenses, with U.S. private health insurance spending reaching $1.6 trillion in 2024. Marpai's focus on technology-driven solutions, including deep learning and data analytics, aligns with the broader industry trend of seeking cost-containment and improved member experience through innovation. However, the high customer attrition rate and intense competition from both large insurers and numerous regional TPAs highlight the significant challenges in capturing and retaining market share in this dynamic environment.

Comparison to Industry Standards

• Marpai's technology-driven approach with "Marpai Saves" and proprietary AI/deep learning models aims to differentiate it from traditional TPAs, similar to how innovative health tech companies like Oscar Health or Bright Health Group have attempted to disrupt the insurance market with technology-first models, though Marpai focuses on the TPA segment for self-insured employers.
• The company competes with large established players such as Aetna, Cigna, and United Healthcare, which offer comprehensive health insurance and TPA services, often leveraging extensive networks and financial resources that smaller, technology-focused players like Marpai may struggle to match in scale or market penetration.
• Marpai's reported 28% customer attrition rate in 2025 is significantly higher than typical industry averages for established TPAs, which often aim for single-digit attrition, indicating a challenge in client retention compared to more stable competitors.
• The reliance on brokers as a primary sales channel is standard in the TPA industry, but the risk of brokers steering clients to other TPAs if Marpai does not deliver competitive pricing or service levels is a common competitive pressure faced by all TPAs.

Management Changes

Corporate Governance

Legal Proceedings

• CMS/Zelis Litigation: Ongoing investigation by CMS regarding a complaint that Marpai Administrators uses a clearinghouse (Zelis) that charges percentage-based fees for Electronic Funds Transfer (EFT) transactions, potentially violating HIPAA. The complaint remains open, but no escalation or additional information is currently required.
• Messer Financial Group Inc. Lawsuit: Civil complaint for breach of contract, with an expert indicating estimated damages exceeding $5 million. Settled on February 5, 2026, requiring a $10,000 cash payment, $25,000 in restricted shares for attorneys' fees, and 400,000 restricted shares in installments through July 2027. A contingent payment of an additional $250,000 cash or restricted shares is due by January 3, 2028, if the total value of the stock consideration is less than $1,000,000.

Related Party Transactions

• HillCour Investment Fund, LLC (controlled by CEO Damien Lamendola) participated in multiple private placements, purchasing significant amounts of common stock in December 2023, January 2024, March 2024, August 2024, July 2025, September 2025, and November 2025.
• Insiders, including Chairman Yaron Eitan, Director Robert Pons, CFO Steve Johnson, former President and COO John Powers, and an immediate family member of the CEO, participated in private placements in January 2024, December 2024, and November 2025, purchasing common stock and warrants.
• CEO Damien Lamendola issued two promissory notes from the company totaling $660,000 ($410,000 on February 12, 2026, and $250,000 on March 9, 2026), both accruing 12.0% interest per annum and due by April 11, 2026, and May 10, 2026, respectively.
• Former President of Product and Development, Mr. Finger, received consulting fees and equity awards (RSUs and stock options) as part of a separation and advisory agreement, including 400,000 stock options exercisable at $0.95 per share.

Stakeholder Impact

• Shareholders: Face significant dilution risk from ongoing equity raises and stock incentive plans. The delisting from Nasdaq to OTCQX and "penny stock" designation negatively impact liquidity and market perception. The "going concern" doubt poses a fundamental risk to investment value.
• Employees: Workforce reduction of 11 full-time equivalent positions (approximately 10%) as part of strategic realignment. Equity awards serve as an incentive, but the company's financial instability could impact job security.
• Customers (Self-insured Employers): High attrition rate indicates dissatisfaction or competitive pressures. The strategic realignment aims to improve service and cost structure, potentially benefiting remaining and future clients.
• Creditors: The company's substantial debt ($11.0 million short-term, $17.2 million long-term) and "going concern" doubt increase credit risk. The Senior Secured Convertible Debentures are secured by company assets.
• Suppliers/Vendors: Some vendors received common stock or RSUs for services, indicating potential cash flow constraints for traditional payments.

Next Steps

• Raise additional capital through equity and/or debt securities.
• Implement additional cost reduction actions.
• Complete strategic operational realignment by the end of Q2 2026, including consolidating claims processing and workforce reduction.
• Realize significant annualized operating expense savings starting in H2 2026 from the realignment.
• Continue to evaluate additional funding alternatives.
• Potentially divest non-strategic assets.
• Monitor and respond to the CMS/Zelis litigation.
• Make installment payments for the Messer Financial Group Inc. settlement (July 1, 2026, January 1, 2027, July 1, 2027, and potential contingent payment January 3, 2028).
• Repay promissory notes to CEO Damien Lamendola by April 11, 2026 ($410,000) and May 10, 2026 ($250,000).

Key Dates

Recommendation

The filing presents a dire financial situation for Marpai, Inc., with the independent auditor explicitly raising 'substantial doubt about our ability to continue as a going concern.' This is compounded by a significant 36% revenue decline, a high 28% customer attrition rate, and persistent negative working capital and accumulated deficit. While management is undertaking restructuring and cost-cutting measures, the need for continuous capital raises, including recent promissory notes from the CEO, highlights severe liquidity challenges. The delisting from Nasdaq and the 'penny stock' designation further erode investor confidence and market liquidity. Given these fundamental financial weaknesses and the explicit going concern warning, a seasoned investor would likely recommend a strong sell to mitigate further losses.

Keywords

Healthcare Technology, TPA, Third Party Administrator, Self-Insured Employers, Health Plan Administration, AI in Healthcare, Deep Learning, Cost Containment, Marpai, MRAI, SEC Filing, 10-K, Financial Reporting, Going Concern, Customer Attrition, Private Placement, Corporate Governance, Risk Management, OTC Markets, Penny Stock